UVE Form 144: Sale of 24,308 shares valued at $839,598

Universal Insurance Holdings (UVE): Form 144 notice of proposed sale.

Rhea-AI Filing Summary

Universal Insurance Holdings (UVE): Form 144 notice of proposed sale. A holder filed to sell 24,308 common shares, with an aggregate market value of $839,598.32. The filing lists Raymond James & Associates as broker and indicates an approximate sale date of 11/14/2025 on the NYSE.

The shares listed for sale were acquired in lieu of compensation on two dates: 7,298 shares on 01/13/2020 and 17,010 shares on 01/22/2018. As context, 28,286,229 shares were outstanding at the time shown in the notice; this is a baseline figure, not the amount being offered. The filing also reports a recent sale activity: Jon Springer sold 35,435 common shares on 10/30/2025 for $1,111,302.98.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/14/2025 - 02:20 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001492994
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	UNIVERSAL INSURANCE HOLDINGS, INC.
SEC File Number	001-33251
Address of Issuer	1110 W. COMMERCIAL BLVD. SUITE 100 FORT LAUDERDALE FLORIDA 33309
Phone	954-958-1200
Name of Person for Whose Account the Securities are To Be Sold	Springer Jon
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates 880 Carillon Parkway St. Petersburg FL 33716	24308	839598.32	28286229	11/14/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/13/2020	In Lieu of Compensation	Issuer			7298	01/13/2020	Cash
Common	01/22/2018	In Lieu of Compensation	Issuer			17010	01/22/2018	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jon Springer 845 Govern Cir Saint Paul MN 55123	Common	10/30/2025	35435	1111302.98

144: Remarks and Signature

Remarks
Date of Notice	11/14/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Maressia Rooks-Bailey, as duly authorized representative of Raymond James & Associates, Inc., as attorney-in-fact for Jon Springer
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)